{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:47:58Z","timestamp":1793396878064,"version":"4.5.0"},"reference-count":123,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2018A0303130333"],"award-info":[{"award-number":["2018A0303130333"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003785","name":"Guangdong Medical Research Foundation","doi-asserted-by":"publisher","award":["A2018245"],"award-info":[{"award-number":["A2018245"]}],"id":[{"id":"10.13039\/501100003785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005145","name":"Basic Research Program of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20180278"],"award-info":[{"award-number":["BK20180278"]}],"id":[{"id":"10.13039\/501100005145","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2019M663271"],"award-info":[{"award-number":["2019M663271"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jconrel.2021.03.029","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T18:27:04Z","timestamp":1616783224000},"page":"129-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"special_numbering":"C","title":["BBB-crossing adeno-associated virus vector: An excellent gene delivery tool for CNS disease treatment"],"prefix":"10.1016","volume":"333","author":[{"given":"Wenli","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhana","family":"Akter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinqiu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizheng","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2021.03.029_bb0005","article-title":"Highlights of the 2019 Society for Neuro-Oncology Inaugural Brain Metastases Conference: establishing a dedicated meeting to address an unmet need in the field","volume":"2","author":"Zuccato","year":"2020","journal-title":"Neuro-Oncol. Adv."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0010","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.drudis.2017.11.010","article-title":"Personalized nanomedicine for CNS diseases","volume":"23","author":"Kaushik","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2021.03.029_bb0015","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/s41583-019-0233-2","article-title":"B cells in autoimmune and neurodegenerative central nervous system diseases","volume":"20","author":"Sabatino","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0020","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S2215-0366(17)30293-6","article-title":"The blood-brain barrier in psychosis","volume":"5","author":"Pollak","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jconrel.2021.03.029_bb0025","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.cell.2015.10.067","article-title":"Establishment and dysfunction of the blood-brain barrier","volume":"163","author":"Zhao","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2021.03.029_bb0030","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrd.2015.21","article-title":"From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery","volume":"15","author":"Banks","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0035","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1007\/s12035-015-9672-6","article-title":"Glucose transporters at the blood-brain barrier: function, regulation and gateways for drug delivery","volume":"54","author":"Patching","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0040","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1089\/hum.2016.087","article-title":"Adeno-associated virus-based gene therapy for CNS diseases","volume":"27","author":"Hocquemiller","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0045","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nature15818","article-title":"Gene therapy returns to Centre stage","volume":"526","author":"Naldini","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2021.03.029_bb0050","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.ymthe.2017.02.019","article-title":"Progress toward gene therapy for Duchenne muscular dystrophy","volume":"25","author":"Chamberlain","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0055","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/cts.12466","article-title":"Gene therapy 2017: progress and future directions","volume":"10","author":"Keeler","year":"2017","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0060","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1517\/14712598.2016.1134480","article-title":"Vectors and strategies for nonviral cancer gene therapy","volume":"16","author":"Pahle","year":"2016","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0065","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0070","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1182\/bloodadvances.2020002142","article-title":"Gene therapy for hemophilia: anticipating the unexpected","volume":"4","author":"Pierce","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0075","first-page":"543","article-title":"Gene therapy for color blindness","volume":"90","author":"Hassall","year":"2017","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0080","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ymthe.2020.01.004","article-title":"Muscle-directed delivery of an AAV1 vector leads to capsid-specific T cell exhaustion in nonhuman primates and humans","volume":"28","author":"Gernoux","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0085","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1146\/annurev-virology-092818-015530","article-title":"Recombinant adeno-associated virus gene therapy in light of Luxturna (and Zolgensma and Glybera): where are we, and how did we get Here?","volume":"6","author":"Keeler","year":"2019","journal-title":"Ann. Rev. Virol."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0090","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/cgt.2009.8","article-title":"Controlling brain tumor growth by intraventricular administration of an AAV vector encoding IFN-beta","volume":"16","author":"Meijer","year":"2009","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0095","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1084\/jem.20182184","article-title":"rAAV-based brain slice culture models of Alzheimer\u2019s and Parkinson\u2019s disease inclusion pathologies","volume":"216","author":"Croft","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0100","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2015.11.019","article-title":"Recombinant Adeno Associated Viral (AAV) vector type 9 delivery of Ex1-Q138-mutant huntingtin in the rat striatum as a short-time model for in vivo studies in drug discovery","volume":"86","author":"Ceccarelli","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0105","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1038\/mt.2008.168","article-title":"Preventing growth of brain tumors by creating a zone of resistance","volume":"16","author":"Maguire","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0110","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/978-1-4939-9139-6_8","article-title":"Intravenous infusion of AAV for widespread gene delivery to the nervous system","volume":"1950","author":"Gessler","year":"2019","journal-title":"Methods Mol. Biol. (Clifton, N.J.)"},{"key":"10.1016\/j.jconrel.2021.03.029_bb0115","first-page":"1508","article-title":"Systemic AAV9-IFN\u03b2 gene delivery treats highly invasive glioblastoma","volume":"18","author":"GuhaSarkar","year":"2016","journal-title":"Neuro-oncology"},{"key":"10.1016\/j.jconrel.2021.03.029_bb0120","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1096\/fj.14-269092","article-title":"Systemic gene delivery following intravenous administration of AAV9 to fetal and neonatal mice and late-gestation nonhuman primates","volume":"29","author":"Mattar","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0125","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/jclinpath-2019-205952","article-title":"Molecular pathology of neurodegenerative diseases: principles and practice","volume":"72","author":"Kovacs","year":"2019","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0130","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/mt.2009.71","article-title":"Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons","volume":"17","author":"Duque","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0135","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ymthe.2017.10.017","article-title":"Mapping the structural determinants required for AAVrh.10 transport across the blood-brain barrier","volume":"26","author":"Albright","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0140","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/nn.4593","article-title":"Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems","volume":"20","author":"Chan","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0145","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nbt.3440","article-title":"Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain","volume":"34","author":"Deverman","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0150","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/mt.2009.246","article-title":"Systematic evaluation of AAV vectors for liver directed gene transfer in murine models","volume":"18","author":"Wang","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0155","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrn1824","article-title":"Astrocyte-endothelial interactions at the blood-brain barrier","volume":"7","author":"Abbott","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0160","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.pt.2019.04.010","article-title":"Blood-brain barrier in cerebral malaria: pathogenesis and therapeutic intervention","volume":"35","author":"Nishanth","year":"2019","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0165","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.placenta.2016.12.005","article-title":"Review: the blood-brain barrier; protecting the developing fetal brain","volume":"54","author":"Goasdou\u00e9","year":"2017","journal-title":"Placenta"},{"key":"10.1016\/j.jconrel.2021.03.029_bb0170","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nature09513","article-title":"Pericytes are required for blood-brain barrier integrity during embryogenesis","volume":"468","author":"Daneman","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2021.03.029_bb0175","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2015.1138017","article-title":"Tight junction modulation of the blood brain barrier: CNS delivery of small molecules","volume":"4","author":"Greene","year":"2016","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.jconrel.2021.03.029_bb0180","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.tins.2015.08.003","article-title":"The molecular constituents of the blood-brain barrier","volume":"38","author":"Chow","year":"2015","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0185","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/ana.23648","article-title":"The blood-brain barrier in health and disease","volume":"72","author":"Daneman","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0190","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/0271678X16679420","article-title":"Age-associated physiological and pathological changes at the blood-brain barrier: a review","volume":"37","author":"Erd\u0151","year":"2017","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0195","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/ca.23083","article-title":"Blood brain barrier: A review of its anatomy and physiology in health and disease","volume":"31","author":"Sharif","year":"2018","journal-title":"Clin. Anat. (New York, N.Y.)"},{"key":"10.1016\/j.jconrel.2021.03.029_bb0200","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2017.1373897","article-title":"The blood brain barrier: insights from development and ageing","volume":"5","author":"Delaney","year":"2017","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.jconrel.2021.03.029_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcdb.2015.03.006","article-title":"Blood-brain barrier in health and disease","volume":"38","author":"Friedman","year":"2015","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0210","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/10717544.2019.1616235","article-title":"A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain\/brain tumor barriers for glioblastoma treatment","volume":"26","author":"Wang","year":"2019","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0215","doi-asserted-by":"crossref","first-page":"119491","DOI":"10.1016\/j.biomaterials.2019.119491","article-title":"Nanomaterial-based blood-brain-barrier (BBB) crossing strategies","volume":"224","author":"Xie","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2021.03.029_bb0220","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s40259-018-0309-y","article-title":"Emerging technologies for delivery of biotherapeutics and gene therapy across the blood-brain barrier","volume":"32","author":"Stanimirovic","year":"2018","journal-title":"BioDrugs"},{"key":"10.1016\/j.jconrel.2021.03.029_bb0225","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/neuonc\/nov164","article-title":"Strategies to improve delivery of anticancer drugs across the blood-brain barrier to treat glioblastoma","volume":"18","author":"Oberoi","year":"2016","journal-title":"Neuro-oncology"},{"key":"10.1016\/j.jconrel.2021.03.029_bb0230","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3390\/pharmaceutics7030275","article-title":"Facilitation of drug transport across the blood-brain barrier with ultrasound and microbubbles","volume":"7","author":"Meairs","year":"2015","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2021.03.029_bb0235","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41576-019-0205-4","article-title":"Engineering adeno-associated virus vectors for gene therapy","volume":"21","author":"Li","year":"2020","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0240","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40259-017-0234-5","article-title":"Adeno-Associated Virus (AAV) as a vector for gene therapy","volume":"31","author":"Naso","year":"2017","journal-title":"BioDrugs"},{"key":"10.1016\/j.jconrel.2021.03.029_bb0245","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1038\/mt.2013.138","article-title":"A single intravenous rAAV injection as late as P20 achieves efficacious and sustained CNS gene therapy in Canavan mice","volume":"21","author":"Ahmed","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0250","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.omtm.2020.07.011","article-title":"AAV-mediated ApoC2 gene therapy: reversal of severe hypertriglyceridemia and rescue of neonatal death in ApoC2-deficient hamsters","volume":"18","author":"Yang","year":"2020","journal-title":"Mol. Therapy Methods Clin. Dev."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0255","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.omtm.2020.07.003","article-title":"Gene therapy preserves retinal structure and function in a mouse model of NMNAT1-associated retinal degeneration","volume":"18","author":"Greenwald","year":"2020","journal-title":"Mol. Therapy Methods Clin. Dev."},{"issue":"10","key":"10.1016\/j.jconrel.2021.03.029_bb0260","doi-asserted-by":"crossref","first-page":"806","DOI":"10.2174\/1566524020999200730181042","article-title":"Recent advances in the analysis full\/empty capsid ratio and genome integrity of adeno-associated virus (AAV) gene delivery vectors","volume":"20","author":"Hajba","year":"2020","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0265","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jconrel.2016.01.001","article-title":"Adeno-associated virus (AAV) vectors in cancer gene therapy","volume":"240","author":"Santiago-Ortiz","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.03.029_bb0270","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1016\/j.ymthe.2018.07.011","article-title":"Systemic AAV micro-dystrophin gene therapy for Duchenne muscular dystrophy","volume":"26","author":"Duan","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0275","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.neuron.2019.02.017","article-title":"Therapeutic AAV gene transfer to the nervous system: a clinical reality","volume":"101","author":"Hudry","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.jconrel.2021.03.029_bb0280","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1038\/s41467-019-11321-7","article-title":"Standard screening methods underreport AAV-mediated transduction and gene editing","volume":"10","author":"Lang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0285","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ymthe.2017.11.019","article-title":"Triple vectors expand AAV transfer capacity in the retina","volume":"26","author":"Maddalena","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0290","doi-asserted-by":"crossref","first-page":"10613","DOI":"10.1073\/pnas.90.22.10613","article-title":"Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector","volume":"90","author":"Flotte","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0295","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ng1094-148","article-title":"Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain","volume":"8","author":"Kaplitt","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0300","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.ymthe.2006.02.004","article-title":"AAV serotype 8-mediated gene delivery of a soluble VEGF receptor to the CNS for the treatment of glioblastoma","volume":"13","author":"Harding","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0305","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/nn.4620","article-title":"AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma","volume":"20","author":"Chow","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0310","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.neuron.2016.09.021","article-title":"A designer AAV variant permits efficient retrograde access to projection neurons","volume":"92","author":"Tervo","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.jconrel.2021.03.029_bb0315","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nature12875","article-title":"Selection and evaluation of clinically relevant AAV variants in a xenograft liver model","volume":"506","author":"Lisowski","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2021.03.029_bb0320","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.mcn.2010.12.003","article-title":"Negative impact of rAAV2 mediated expression of SOCS3 on the regeneration of adult retinal ganglion cell axons","volume":"46","author":"Hellstr\u00f6m","year":"2011","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0325","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/gt.2012.101","article-title":"Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates","volume":"20","author":"Gray","year":"2013","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0330","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.biomaterials.2018.05.041","article-title":"Blood-brain barrier shuttle peptides enhance AAV transduction in the brain after systemic administration","volume":"176","author":"Zhang","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2021.03.029_bb0335","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/1878-0261.12020","article-title":"Intracranial AAV-IFN-\u03b2 gene therapy eliminates invasive xenograft glioblastoma and improves survival in orthotopic syngeneic murine model","volume":"11","author":"GuhaSarkar","year":"2017","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0340","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nrn3617","article-title":"Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity","volume":"15","author":"Xanthos","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0345","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/glia.23571","article-title":"Neuroinflammation in the central nervous system: symphony of glial cells","volume":"67","author":"Yang","year":"2019","journal-title":"Glia"},{"key":"10.1016\/j.jconrel.2021.03.029_bb0350","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ana.25146","article-title":"Central vein sign differentiates multiple sclerosis from central nervous system inflammatory vasculopathies","volume":"83","author":"Maggi","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0355","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nbt.1515","article-title":"Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes","volume":"27","author":"Foust","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0360","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.omtm.2018.03.004","article-title":"A rationally engineered capsid variant of AAV9 for systemic CNS-directed and peripheral tissue-detargeted gene delivery in neonates","volume":"9","author":"Wang","year":"2018","journal-title":"Mol. Therapy Methods Clin. Dev."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0365","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1038\/mt.2011.98","article-title":"Several rAAV vectors efficiently cross the blood-brain barrier and transduce neurons and astrocytes in the neonatal mouse central nervous system","volume":"19","author":"Zhang","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0370","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/mt.2014.68","article-title":"Global CNS transduction of adult mice by intravenously delivered rAAVrh.8 and rAAVrh.10 and nonhuman primates by rAAVrh.10","volume":"22","author":"Yang","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0375","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/mt.2010.279","article-title":"MicroRNA-regulated, systemically delivered rAAV9: a step closer to CNS-restricted transgene expression","volume":"19","author":"Xie","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0380","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41434-019-0075-6","article-title":"Astrocyte-selective AAV gene therapy through the endogenous GFAP promoter results in robust transduction in the rat spinal cord following injury","volume":"26","author":"Griffin","year":"2019","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0385","doi-asserted-by":"crossref","DOI":"10.3390\/v11020102","article-title":"Adeno-associated Virus (AAV) versus Immune Response","volume":"11","author":"Rabinowitz","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.jconrel.2021.03.029_bb0390","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.omtm.2018.09.003","article-title":"Adeno-associated virus neutralizing antibodies in large animals and their impact on brain Intraparenchymal gene transfer","volume":"11","author":"Wang","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0395","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.omtn.2019.04.015","article-title":"Targeted transgene activation in the brain tissue by systemic delivery of engineered AAV1 expressing CRISPRa","volume":"16","author":"Lau","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.jconrel.2021.03.029_bb0400","doi-asserted-by":"crossref","first-page":"108887","DOI":"10.1016\/j.jneumeth.2020.108887","article-title":"Retrograde gene transfer into neural pathways mediated by adeno-associated virus (AAV)-AAV receptor interaction","volume":"345","author":"Sano","year":"2020","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.jconrel.2021.03.029_bb0405","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/mt.2014.240","article-title":"Long-term correction of Sandhoff disease following intravenous delivery of rAAV9 to mouse neonates","volume":"23","author":"Walia","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0410","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/jnc.13861","article-title":"Trafficking of adeno-associated virus vectors across a model of the blood-brain barrier; a comparative study of transcytosis and transduction using primary human brain endothelial cells","volume":"140","author":"Merkel","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0415","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41564-018-0356-7","article-title":"Adeno-associated virus 2 bound to its cellular receptor AAVR","volume":"4","author":"Zhang","year":"2019","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0420","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.44707","article-title":"Structure of the gene therapy vector, adeno-associated virus with its cell receptor, AAVR","volume":"8","author":"Meyer","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.jconrel.2021.03.029_bb0425","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.ymthe.2019.02.013","article-title":"The GPI-linked protein LY6A drives AAV-PHP.B transport across the blood-brain barrier","volume":"27","author":"Hordeaux","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0430","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1089\/hum.2019.186","article-title":"Ly6a Differential Expression in Blood-Brain Barrier Is Responsible for Strain Specific Central Nervous System Transduction Profile of AAV-PHP.B","volume":"31","author":"Batista","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0435","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225206","article-title":"Delivering genes across the blood-brain barrier: LY6A, a novel cellular receptor for AAV-PHP.B capsids","volume":"14","author":"Huang","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2021.03.029_bb0440","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1089\/hum.2015.167","article-title":"Efficient transduction of corneal stroma by adeno-associated viral serotype vectors for implications in gene therapy of corneal diseases","volume":"27","author":"Lu","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0445","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1089\/hgtb.2014.093","article-title":"Efficient production of dual recombinant adeno-associated viral vectors for factor VIII delivery","volume":"25","author":"Wang","year":"2014","journal-title":"Human Gene Ther. Methods"},{"key":"10.1016\/j.jconrel.2021.03.029_bb0450","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/mt.2016.84","article-title":"In vivo selection yields AAV-B1 capsid for central nervous system and muscle gene therapy","volume":"24","author":"Choudhury","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0455","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/mt.2015.231","article-title":"Widespread central nervous system gene transfer and silencing after systemic delivery of novel AAV-AS vector","volume":"24","author":"Choudhury","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0460","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/nature19835","article-title":"Corrigendum: an essential receptor for adeno-associated virus infection","volume":"539","author":"Pillay","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2021.03.029_bb0465","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/hep.29112","article-title":"Sodium taurocholate cotransporting polypeptide is the limiting host factor of hepatitis B virus infection in macaque and pig hepatocytes","volume":"66","author":"Lempp","year":"2017","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/j.jconrel.2021.03.029_bb0470","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00391-17","article-title":"Adeno-Associated Virus (AAV) serotypes have distinctive interactions with domains of the cellular AAV receptor","volume":"91","author":"Pillay","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0475","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1038\/s41467-019-11668-x","article-title":"Divergent engagements between adeno-associated viruses with their cellular receptor AAVR","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0480","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.omtn.2019.09.015","article-title":"AAVR-displaying interfaces: serotype-independent adeno-associated virus capture and local delivery systems","volume":"18","author":"Kim","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.jconrel.2021.03.029_bb0485","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41434-019-0078-3","article-title":"Polarized AAVR expression determines infectivity by AAV gene therapy vectors","volume":"26","author":"Hamilton","year":"2019","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0490","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/mt.2016.49","article-title":"AAVR: a multi-serotype receptor for AAV","volume":"24","author":"Summerford","year":"2016","journal-title":"Mol. Ther."},{"issue":"7","key":"10.1016\/j.jconrel.2021.03.029_bb0495","first-page":"e338","article-title":"Intracranial injection of adeno-associated viral vectors","volume":"5","author":"Lowery","year":"2016","journal-title":"J. Visualized Exp."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0500","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2016.49","article-title":"CNS-restricted transduction and CRISPR\/Cas9-mediated gene deletion with an engineered AAV vector","volume":"5","author":"Murlidharan","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.jconrel.2021.03.029_bb0505","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.ymthe.2018.01.009","article-title":"Long-term improvement of neurological signs and metabolic dysfunction in a mouse model of Krabbe\u2019s disease after global gene therapy","volume":"26","author":"Marshall","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0510","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/gt.2010.105","article-title":"Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distribution","volume":"18","author":"Prasad","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0515","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41596-018-0097-3","article-title":"Systemic AAV vectors for widespread and targeted gene delivery in rodents","volume":"14","author":"Challis","year":"2019","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0520","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2008.76","article-title":"Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection","volume":"16","author":"Zincarelli","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0525","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ymthe.2004.08.031","article-title":"Systemic mannitol-induced hyperosmolality amplifies rAAV2-mediated striatal transduction to a greater extent than local co-infusion","volume":"11","author":"Burger","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0530","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/hum.2009.127","article-title":"Comparison of adeno-associated virus pseudotype 1, 2, and 8 vectors administered by intramuscular injection in the treatment of murine phenylketonuria","volume":"21","author":"Rebuffat","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0535","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1089\/hum.2015.097","article-title":"Systemic vascular transduction by capsid mutant adeno-associated virus after intravenous injection","volume":"26","author":"Lipinski","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0540","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/mt.2009.15","article-title":"AAV9: a potential blood-brain barrier buster","volume":"17","author":"Manfredsson","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0545","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/cgt.2010.11","article-title":"Persistent expression of biologically active anti-HER2 antibody by AAVrh.10-mediated gene transfer","volume":"17","author":"Wang","year":"2010","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0550","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1038\/mt.2014.107","article-title":"Gene transfer properties and structural modeling of human stem cell-derived AAV","volume":"22","author":"Smith","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0555","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/mt.2011.95","article-title":"AAV9: over the fence and into the woods","volume":"19","author":"Forsayeth","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0560","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1089\/hum.2010.016","article-title":"Enhanced long-term transduction and multilineage engraftment of human hematopoietic stem cells transduced with tyrosine-modified recombinant adeno-associated virus serotype 2","volume":"21","author":"Kauss","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0565","doi-asserted-by":"crossref","first-page":"974819","DOI":"10.1155\/2013\/974819","article-title":"Systemic delivery of tyrosine-mutant AAV vectors results in robust transduction of neurons in adult mice","volume":"2013","author":"Iida","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0570","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/mt.2008.269","article-title":"High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors","volume":"17","author":"Petrs-Silva","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0575","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.omtm.2019.10.007","article-title":"Selection of an efficient AAV vector for robust CNS transgene expression","volume":"15","author":"Hanlon","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0580","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.coviro.2016.07.006","article-title":"Systemic delivery of adeno-associated viral vectors","volume":"21","author":"Duan","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0585","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ymthe.2018.01.005","article-title":"Taking a hint from structural biology: to better understand AAV transport across the BBB","volume":"26","author":"Wang","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0590","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1038\/s41467-019-10588-0","article-title":"Hypoxia-enhanced blood-brain barrier Chip recapitulates human barrier function and shuttling of drugs and antibodies","volume":"10","author":"Park","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0595","doi-asserted-by":"crossref","first-page":"8409","DOI":"10.1039\/C8SC02415D","article-title":"Branched BBB-shuttle peptides: chemoselective modification of proteins to enhance blood-brain barrier transport","volume":"9","author":"D\u00edaz-Perlas","year":"2018","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0600","doi-asserted-by":"crossref","first-page":"592","DOI":"10.15252\/emmm.201606407","article-title":"Brain endothelial cell-targeted gene therapy of neurovascular disorders","volume":"8","author":"Marchi\u00f2","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0605","doi-asserted-by":"crossref","first-page":"609","DOI":"10.15252\/emmm.201506078","article-title":"A brain microvasculature endothelial cell-specific viral vector with the potential to treat neurovascular and neurological diseases","volume":"8","author":"K\u00f6rbelin","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0610","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1089\/hum.2019.027","article-title":"Capsid engineering overcomes barriers toward adeno-associated virus vector-mediated transduction of endothelial cells","volume":"30","author":"Zhang","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2021.03.029_bb0615","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1517\/14712598.2016.1114096","article-title":"Gene therapy for neurological disorders","volume":"16","author":"Choong","year":"2016","journal-title":"Expert. Opin. Biol. Ther."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921001401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921001401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:55:28Z","timestamp":1759161328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365921001401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":123,"alternative-id":["S0168365921001401"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.03.029","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BBB-crossing adeno-associated virus vector: An excellent gene delivery tool for CNS disease treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.03.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}